Scale Of Off-Patent Savings Ramps Up As Impact Of Biologic LOEs Increases
Half Of Immunology Market Will Face Losses Of Exclusivity
IQVIA’s latest Global Use of Medicines report demonstrates the impact generics and biosimilars are set to have on global pharmaceutical spending, with losses of exclusivity expected to dampen spending growth over the next five years.
